A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development

@article{Arora2009ABO,
  title={A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development},
  author={Ashish Arora and Alfonso Gambardella and Laura Magazzini and Fabio Pammolli},
  journal={Management Science},
  year={2009},
  volume={55},
  pages={1638-1653}
}
Service) registry number (when available) to distinguish me-too and second-generation molecules from first-in-class compounds (see Reddy 2003). it easier to improve upon existing remedies. We also expect first-in-class compounds to be drawn from an inferior distribution because there is less information about potential side effects. Unfortunately, in almost 40% of cases it is impossible to classify the molecule under study because its chemical characteristics are not available. To properly… CONTINUE READING